Biochemistry, Genetics and Molecular Biology
KRAS
100%
Cancer Cell
66%
Mutation
66%
Epidermal Growth Factor Receptor
66%
Monoclonal Antibody
50%
Mouse
33%
Wild Type
16%
Binding Affinity
16%
Flow Cytometry
16%
Nude Mouse
16%
Monoclonal Antibodies
16%
Antibody Dependent Cellular Cytotoxicity
16%
Antineoplastic Activity
16%
Virus Oncogene
16%
Rat
16%
Complement Dependent Cytotoxicity
16%
Experiment
16%
Metastasis Inhibition
16%
Medicine and Dentistry
Cancer Cell
66%
Monoclonal Antibody
66%
Anti-Epidermal Growth Factor Receptor
50%
Neoplasm
33%
Antibody
33%
In Vitro
16%
Combination Therapy
16%
Metastatic Carcinoma
16%
Antineoplastic Activity
16%
Flow Cytometry
16%
Antibody Dependent Cellular Cytotoxicity
16%
Epidermal Growth Factor Receptor
16%
Immunoglobulin G1
16%
Immunoglobulin G2a
16%
Binding Affinity
16%
Sarcoma
16%
Virus Oncogene
16%
Complement Dependent Cytotoxicity
16%
Metastasis Inhibition
16%
Therapeutic Procedure
16%
Patient
16%
Cells
16%
Analysis
16%
Liver
16%
Inpatient
16%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Colorectal Cancer
83%
Monoclonal Antibody
66%
Colorectal Cancer
66%
Antibody
33%
Neoplasm
33%
Mouse
33%
Epidermal Growth Factor Receptor
16%
Metastasis
16%
Nude Mouse
16%
Immunoglobulin G1
16%
Immunoglobulin G2a
16%
Sarcoma
16%
Metastasis Inhibition
16%
Rat
16%
Immunology and Microbiology
Mutation
66%
Cancer Cell
66%
Monospecific Antibody
33%
Mouse
33%
Wild Type
16%
Antibody-Dependent Cell-Mediated Cytotoxicity
16%
Immunoglobulin G2a
16%
Immunoglobulin G1
16%
Binding Affinity
16%
Nude Mouse
16%
Antineoplastic Activity
16%
Complement Dependent Cytotoxicity
16%
Rat
16%
Experiment
16%
Cells
16%
Liver
16%
Virus Oncogene
16%
Metastasis Inhibition
16%
Neuroscience
Antibodies
33%
Binding Affinity
16%
In Vitro
16%
In Vivo
16%
Antibody-Dependent Cell-Mediated Cytotoxicity
16%
Flow Cytometry
16%
Metastasis
16%
Immunoglobulin G2a
16%
Immunoglobulin G1
16%
Virus Oncogene
16%
Complement Dependent Cytotoxicity
16%